SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (3902)8/5/2001 9:43:39 PM
From: DanZ  Read Replies (3) of 5582
 
You've got to be kidding, Hank. Your conspiracy theory is a joke. Gum Tech knew nothing about CNS's study, and Reuters called Dr. Davidson at Gel Tech for an interview. It didn't happen the other way around. Why would CNS conduct a study for the benefit of Gum Tech? If Gum Tech paid CNS it would be easy to find in an audit. Man, what a stretch your story is, and what a joke you are. The most logical reason that CNS conducted the study is because they were considering releasing a zinc based product that they could claim reduces the duration and severity of the common cold. They couldn't get around Gel Tech's patent so they had to change the ingredients, viscosity, and concentration of zinc. The smoke and mirrors are all yours. Anyone that reads your garbage can see that. By the way, CNS (or anyone else) wouldn't have to ask Gum Tech for permission to study Zicam. However, if they say something derogatory and don't have ample proof, they would be open to liability.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext